Magdalena Markowicz-Piasecka

2.2k total citations
68 papers, 1.7k citations indexed

About

Magdalena Markowicz-Piasecka is a scholar working on Molecular Biology, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Magdalena Markowicz-Piasecka has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 14 papers in Pharmacology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Magdalena Markowicz-Piasecka's work include Metabolism, Diabetes, and Cancer (15 papers), Diabetes Treatment and Management (12 papers) and Cholinesterase and Neurodegenerative Diseases (10 papers). Magdalena Markowicz-Piasecka is often cited by papers focused on Metabolism, Diabetes, and Cancer (15 papers), Diabetes Treatment and Management (12 papers) and Cholinesterase and Neurodegenerative Diseases (10 papers). Magdalena Markowicz-Piasecka collaborates with scholars based in Poland, Finland and Czechia. Magdalena Markowicz-Piasecka's co-authors include Elżbieta Mikiciuk‐Olasik, Joanna Sikora, Paweł Szymański, Kristiina M. Huttunen, Aleksandra Szydłowska, Marlena Broncel, Johanna Huttunen, Maciej Chałubiński, Jerzy Kruk and Barbara Płytycz and has published in prestigious journals such as Scientific Reports, Chemosphere and International Journal of Molecular Sciences.

In The Last Decade

Magdalena Markowicz-Piasecka

65 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Markowicz-Piasecka Poland 22 697 232 216 187 187 68 1.7k
Elżbieta Mikiciuk‐Olasik Poland 23 711 1.0× 188 0.8× 370 1.7× 328 1.8× 159 0.9× 78 1.8k
Chiung‐Tong Chen Taiwan 29 1.2k 1.7× 230 1.0× 265 1.2× 130 0.7× 430 2.3× 84 2.8k
Punniyakoti T. Veeraveedu Japan 33 1.0k 1.5× 336 1.4× 503 2.3× 181 1.0× 175 0.9× 96 3.1k
Mükerrem Betül Yerer Türkiye 20 1.1k 1.6× 137 0.6× 195 0.9× 249 1.3× 246 1.3× 79 2.5k
Ivanov As Russia 22 944 1.4× 101 0.4× 172 0.8× 168 0.9× 129 0.7× 183 1.8k
M. J. Nanjan India 20 757 1.1× 222 1.0× 448 2.1× 167 0.9× 156 0.8× 85 2.1k
Benjamin P. Ross Australia 26 553 0.8× 135 0.6× 277 1.3× 247 1.3× 85 0.5× 59 1.7k
Jingjing Wu China 27 918 1.3× 113 0.5× 124 0.6× 181 1.0× 325 1.7× 98 2.2k
Xian‐Li Zhou China 25 1.2k 1.7× 252 1.1× 434 2.0× 430 2.3× 186 1.0× 220 2.7k

Countries citing papers authored by Magdalena Markowicz-Piasecka

Since Specialization
Citations

This map shows the geographic impact of Magdalena Markowicz-Piasecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Markowicz-Piasecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Markowicz-Piasecka more than expected).

Fields of papers citing papers by Magdalena Markowicz-Piasecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Markowicz-Piasecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Markowicz-Piasecka. The network helps show where Magdalena Markowicz-Piasecka may publish in the future.

Co-authorship network of co-authors of Magdalena Markowicz-Piasecka

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Markowicz-Piasecka. A scholar is included among the top collaborators of Magdalena Markowicz-Piasecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Markowicz-Piasecka. Magdalena Markowicz-Piasecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markowicz-Piasecka, Magdalena, et al.. (2025). Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy – a review. Journal of Pharmacology and Experimental Therapeutics. 392(9). 103658–103658. 1 indexed citations
2.
Kowalczyk, Tomasz, Magdalena Markowicz-Piasecka, Joanna Sikora, et al.. (2025). Anticancer Activity of the Marine-Derived Compound Bryostatin 1: Preclinical and Clinical Evaluation. International Journal of Molecular Sciences. 26(16). 7765–7765. 1 indexed citations
3.
4.
Rybarczyk‐Pirek, Agnieszka J., Justyna Dominikowska, Magdalena Markowicz-Piasecka, et al.. (2024). Silver Complexes of Miconazole and Metronidazole: Potential Candidates for Melanoma Treatment. International Journal of Molecular Sciences. 25(10). 5081–5081. 3 indexed citations
5.
6.
Ciach, Tomasz, et al.. (2022). Trends in development and quality assessment of pharmaceutical formulations - F2α analogues in the glaucoma treatment. European Journal of Pharmaceutical Sciences. 180. 106315–106315. 12 indexed citations
7.
8.
Huttunen, Johanna, et al.. (2022). Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs). Pharmaceutics. 14(6). 1234–1234. 13 indexed citations
9.
Markowicz-Piasecka, Magdalena, et al.. (2021). Ganciclovir and Its Hemocompatible More Lipophilic Derivative Can Enhance the Apoptotic Effects of Methotrexate by Inhibiting Breast Cancer Resistance Protein (BCRP). International Journal of Molecular Sciences. 22(14). 7727–7727. 9 indexed citations
10.
Markowicz-Piasecka, Magdalena, et al.. (2021). Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosis. Chemico-Biological Interactions. 345. 109560–109560. 8 indexed citations
11.
Laitinen, Tuomo, Magdalena Markowicz-Piasecka, Marko Lehtonen, et al.. (2021). Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation. Bioorganic Chemistry. 112. 104921–104921. 9 indexed citations
12.
Markowicz-Piasecka, Magdalena, et al.. (2021). Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells. International Journal of Molecular Sciences. 22(11). 5642–5642. 7 indexed citations
13.
Markowicz-Piasecka, Magdalena, et al.. (2020). L-type amino acid transporter 1 (LAT1)-utilizing efflux transporter inhibitors can improve the brain uptake and apoptosis-inducing effects of vinblastine in cancer cells. International Journal of Pharmaceutics. 586. 119585–119585. 9 indexed citations
14.
Adamus-Grabicka, Angelika A., Magdalena Markowicz-Piasecka, Marcin Cieślak, et al.. (2020). Biological Evaluation of 3-Benzylidenechromanones and Their Spiropyrazolines-Based Analogues. Molecules. 25(7). 1613–1613. 23 indexed citations
15.
Markowicz-Piasecka, Magdalena, Johanna Huttunen, Joanna Sikora, & Kristiina M. Huttunen. (2019). Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines. Bioorganic Chemistry. 87. 321–334. 22 indexed citations
16.
Markowicz-Piasecka, Magdalena, et al.. (2019). Generation 2 (G2) – Generation 4 (G4) PAMAM dendrimers disrupt key plasma coagulation parameters. Toxicology in Vitro. 59. 87–99. 10 indexed citations
17.
Markowicz-Piasecka, Magdalena, et al.. (2018). Biocompatibility Studies of Gadolinium Complexes with Iminodiacetic Acid Derivatives. Biological Trace Element Research. 189(2). 426–436. 9 indexed citations
18.
Sikora, Joanna, Magdalena Markowicz-Piasecka, Marlena Broncel, & Elżbieta Mikiciuk‐Olasik. (2014). Extract of Aronia melanocarpa-modified hemostasis: in vitro studies. European Journal of Nutrition. 53(7). 1493–1502. 35 indexed citations
19.
Szymański, Paweł, Magdalena Markowicz-Piasecka, & Elżbieta Mikiciuk‐Olasik. (2012). Zastosowanie nanotechnologii w medycynie i farmacji. 51–56. 3 indexed citations
20.
Szymański, Paweł, et al.. (2010). Neuroimaging diagnosis in neurodegenerative diseases.. PubMed. 13(1). 23–31. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elżbieta Mikiciuk‐Olasik Breakdown of academic impact, for papers by Chiung‐Tong Chen Breakdown of academic impact, for papers by Punniyakoti T. Veeraveedu Breakdown of academic impact, for papers by Mükerrem Betül Yerer Breakdown of academic impact, for papers by Ivanov As Breakdown of academic impact, for papers by M. J. Nanjan Breakdown of academic impact, for papers by Benjamin P. Ross Breakdown of academic impact, for papers by Jingjing Wu Breakdown of academic impact, for papers by Xian‐Li Zhou
Rankless by CCL
2026